As filed with the Securities and Exchange Commission on July 24, 2023 Registration Statement No 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Cadrenal Therapeutics, Inc. (Exact name of Registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 88-0860746 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 822 A1 ...